Nicola Vannini

9PUBLICATIONS
68CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsCell development, proliferation and deathTumour immunologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Dec 15, 2025
Chemotherapy-driven intestinal dysbiosis and indole-3-propionic acid rewire myelopoiesis to promote a metastasis-refractory state.

Ludivine Bersier, L Francisco Lorenzo-Martin, Yi-Hsuan Chiang

|May 20, 2025
Age-associated nicotinamide adenine dinucleotide decline drives CAR-T cell failure.

Helen Carrasco Hope, Jana de Sostoa, Pierpaolo Ginefra

|Feb 28, 2025
Metabolic Alterations in HSCs during Aging and Leukemogenesis.

Yi-Hsuan Chiang, Stephan Emmrich, Nicola Vannini

|Apr 24, 2024
PGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function.

Matteo Morotti, Alizee J Grimm, Helen Carrasco Hope

|Apr 16, 2024
Urolithin-A Promotes CD8+ T Cell-mediated Cancer Immunosurveillance via FOXO1 Activation.

Pierpaolo Ginefra, Helen Carrasco Hope, Yi-Hsuan Chiang

|Oct 04, 2023
Mitochondria Dictate Function and Fate of HSCs and T Cells.

Yingxi Xu, Yi-Hsuan Chiang, Ping-Chih Ho

Pageof 2